
Journey Medical Corp Investor Relations Material
Latest events

Q2 2025
Journey Medical Corp
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Journey Medical Corp
Access all reports
Journey Medical Corporation is a pharmaceutical company specializing in dermatological treatments. Its focus is on developing and commercializing products to address various skin conditions. The company's portfolio includes branded and generic prescription medications, such as Qbrexza, a medicated cloth for hyperhidrosis, and Accutane, a well-known oral treatment for severe acne. Other offerings include Amzeeq and Zilxi, both topical minocycline formulations for acne and rosacea, respectively, and Exelderm, an antifungal cream. The company is headquartered in Scottsdale, Arizona, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
DERM
Country
🇺🇸 United States